Simplex Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Simplex Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,948	Closed	-$395K	–	11010
2021 Q1	$450K	Sell	41,948 -9,513	-18%	-$118K	﹤0.01%	3520
2020 Q4	$0	Buy	51,461 +28,499	+124%	+$411K	﹤0.01%	9395
2020 Q3	$326K	Sell	22,962 -36,141	-61%	-$360K	﹤0.01%	3515
2020 Q2	$0	Buy	+59,103	New	+$366K	﹤0.01%	8698
2018 Q3	–	Sell	-855	Closed	-$5K	–	8355
2018 Q2	$5K	Buy	+855	New	+$5.45K	﹤0.01%	6752

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading's TRIL Position: Q2 2021 in Review

Simplex Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q2 2021, closing a stake of 41,948 shares — an estimated $395K sold.

Simplex Trading first reported a position in TRIL in Q2 2018 and held it in 5 quarters. The position peaked at $450K in Q1 2021. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

Simplex Trading reported no remaining Trillium Therapeutics Inc. position as of Q2 2021 after selling out during the quarter.
Simplex Trading sold 41,948 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $395K.
Simplex Trading first reported a position in Trillium Therapeutics Inc. in Q2 2018 and held it in 5 quarters.
Simplex Trading's Trillium Therapeutics Inc. position peaked at $450K in Q1 2021.
137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.